Taiwan Semiconductor Manufacturing Co. (TSMC) (TW:2330) shares rose Friday after the chipmaker reported record second-quarter earnings, driven by booming demand for AI chips and advanced semiconductors.
The world’s largest contract chipmaker posted a net profit of T$398.3 billion ($13.53 billion) for the April–June quarter, marking a 60.7% year-on-year surge and surpassing analyst expectations. Revenue climbed 38.6% to T$933.79 billion, fueled by strong sales of cutting-edge 3nm, 5nm, and 7nm process technologies.
Boosted by the results, TSMC’s Taipei-listed shares rose 1.8% to T$1,150 on Friday, just shy of their record high of T$1,160. U.S.-listed TSMC shares also gained, closing 3.4% higher earlier in the week.
CEO C.C. Wei credited the growth to escalating demand in high-performance computing and artificial intelligence applications. He emphasized that the AI-driven shift is significantly expanding semiconductor needs globally.
Reflecting strong momentum, TSMC raised its full-year revenue growth forecast to approximately 30% in U.S. dollar terms, up from the previous mid-20% range. The company also issued bullish guidance for the third quarter, projecting revenue between $31.8 billion and $33 billion.
However, Wei cautioned that potential U.S. tariffs and currency fluctuations could weigh on profit margins and impact demand for non-AI chips later in the year.
The outlook triggered mixed responses in the broader semiconductor sector. Japan’s Advantest Corp. (TYO:6857) dropped over 4%, while Tokyo Electron (TYO:8035) slipped 0.6%. South Korea’s Samsung Electronics Co. (KS:005930) dipped 0.2%.
Despite macroeconomic uncertainties, TSMC’s strong earnings highlight the growing role of AI chips in the semiconductor industry and position the company for continued growth amid the AI boom.


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Instagram Outage Disrupts Thousands of U.S. Users
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Washington Post Publisher Will Lewis Steps Down After Layoffs
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast 



